Biomarker Testing and Advancements in EGFR-Mutant NSCLC Treatment Strategies

News
Video

Insights into diagnosing EGFR-mutant lung cancer and explores evolving first-line treatment strategies, incorporating recent developments, combinations, and clinical trial data, while addressing challenges in testing and patient management.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Subscribe Now!
Recent Videos
Related Content
“Exciting Year” for Targeted Therapy Options for Mutated NSCLC, Experts Say

“Exciting Year” for Targeted Therapy Options for Mutated NSCLC, Experts Say

Rina Lokaj
December 24th 2023
Article

During the 2023 European Society of Medical Oncology, experts in the field of lung cancer convened to discuss the use of biomarker testing and updated trial results that were presented.

Recap: Recent Advances in Multiple Myeloma From IMS 2022 and Beyond

Recap: Recent Advances in Multiple Myeloma From IMS 2022 and Beyond

ONCOLOGY Staff
November 5th 2022
Article

A panel of experts in multiple myeloma discusses recent data updates from 2022 International Myeloma Society Annual Meeting and how it influences treatment strategies in clinical practice.

Recap: Recent Research in Multiple Myeloma

Recap: Recent Research in Multiple Myeloma

ONCOLOGY Staff
November 4th 2022
Article

At an Around the Practice program in Charlotte, NC, experts spoke about the most recent research in multiple myeloma.

Recap: Recent Advances in the Treatment of Metastatic Castration-Sensitive Prostate Cancer

Recap: Recent Advances in the Treatment of Metastatic Castration-Sensitive Prostate Cancer

ONCOLOGY Staff
September 18th 2022
Article

Expert oncologists review key studies in the metastatic castration-resistant prostate cancer treatment landscape and discuss how evidence can be applied to clinical practice to improve patient outcomes.

Recap: Mayo Experts Review Treatment Options for Newly Diagnosed Multiple Myeloma

Recap: Mayo Experts Review Treatment Options for Newly Diagnosed Multiple Myeloma

ONCOLOGY Staff
July 17th 2022
Article

Expert panelists review key data from recent meetings on the management of multiple myeloma and consider how these can be applied to clinical practice.

Updates in Treatment of HER2-Positive Breast Cancer and Brain Metastases

Recap: Updates in Treatment of HER2-Positive Breast Cancer and Brain Metastases

ONCOLOGY Staff
July 16th 2022
Article

Sara A. Hurvitz, MD; Stefania Maraka, MD; and Ruta Rao, MD, discuss the evolving landscape of metastatic HER2+ breast cancer, highlighting recent clinical trials and the management of patients with brain metastases.